<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00558454</url>
  </required_header>
  <id_info>
    <org_study_id>Iron for LBW infants</org_study_id>
    <nct_id>NCT00558454</nct_id>
  </id_info>
  <brief_title>Iron Supplementation of Marginally Low Birth Weight Infants</brief_title>
  <acronym>JOHN</acronym>
  <official_title>Randomized, Controlled Study of Iron Supplementation of Infants With Birth Weights 2000-2500 g</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jerring Foundation, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oskar Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iron is essential for brain development and there is a well established association between
      iron deficiency in infants and poor neurological development. In Sweden, about 5% of newborns
      have low birth weight (&lt; 2500 g). Due to small iron stores at birth and rapid postnatal
      growth, they have increased risk of iron deficiency and it is therefore important to prevent
      iron deficiency in this population. However, excessive iron supplementation can have adverse
      effects in infants such as growth impairment. In a randomized, controlled trial, we are
      investigating the effects of 0, 1 or 2 mg/kg/d of iron on brain myelination, cognitive
      development and growth in low birth weight infants.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2004</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurological developement</measure>
    <time_frame>6 months, 3 years and 7 years</time_frame>
    <description>6 mo: Auditory brain stem response (central conduction time) 3 y: CBCL - Parental questionnaire assessing behavioral problems and WIPPSI - test of cognitive functions 7 y: SDQ, 5-15 and CBCL - Parental questionnaires assessing behavioral problems, TeAch - test of behavioral problems and WISC - test of cognitive functions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Growth (weight, length, head circumference, knee-heel length), Morbidity and Iron status (Hemoglobin, ferritin etc)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth, Iron status, and Morbidity</measure>
    <time_frame>3 years and 7 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">380</enrollment>
  <condition>Anemia</condition>
  <condition>Iron-Deficiency</condition>
  <condition>Child Behavior Disorders</condition>
  <condition>Cognitive Manifestations</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg/kg/day from age 6 weeks to 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 mg/kg/day from age 6 weeks to 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iron</intervention_name>
    <description>Ferrous succinate mixture</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <other_name>Ferromyn S, AstraZeneca, Södertälje, Sweden</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Marginally low birth weight (2000-2500 g)

          -  Healthy at inclusion(6 weeks of age)

          -  No previous blood transfusion

          -  No previous iron supplementation

        Exclusion Criteria:

          -  Anemia at inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>39 Days</minimum_age>
    <maximum_age>45 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magnus Domellöf, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Karolinska Hospital (including Danderyd Hospital)</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Umeå University Hospital</name>
      <address>
        <city>Umeå</city>
        <zip>SE-90185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2007</study_first_submitted>
  <study_first_submitted_qc>November 14, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2007</study_first_posted>
  <last_update_submitted>June 4, 2012</last_update_submitted>
  <last_update_submitted_qc>June 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Umeå University</investigator_affiliation>
    <investigator_full_name>Magnus Domellöf</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Iron supplements</keyword>
  <keyword>Infant</keyword>
  <keyword>Low birth weight</keyword>
  <keyword>Prevention of iron deficiency and its physiological consequences</keyword>
  <keyword>Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Child Behavior Disorders</mesh_term>
    <mesh_term>Neurobehavioral Manifestations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

